Four months ago, when Dean Baquet was elevated to the executive editorship of The New York Times, it was hard enough that his promotion came amid the very public firing of his predecessor—a seismic event in the news biz that generated reams of scandalous coverage. Worse still, just as Baquet was attempting to reassure his traumatized newsroom in the wake of Jill Abramson’s abrupt departure, he learned that he had a malignant tumor on his left kidney. “The doctor’s quote to me was something like, ‘I don’t know what your plans are for the next month, but for the next month, you’re mine,’” Baquet (pronounced back-ay) tells me during an exclusive interview in his surprisingly modest office on the third floor of the Times’s Renzo Piano-designed skyscraper. (He has a majestic view of the dingy back entrance of a Hilton hotel.) “It was a complete shock. But I’m fine, by the way. No chemo. They removed the kidney. And it was also an introduction to how public it is to be editor of The New York Times.” Baquet got a lot of media attention for undergoing emergency surgery at Lenox Hill Hospital. He also received what he describes as “a… Read full this story
- New York Times publisher denies sexism, calls Abramson bad manager
- Breast cancer survivors 'do not exercise enough'
- Roche lung cancer drug success adds to pressure on Bristol
- Bowel cancers 'spotted too late'
- Food may influence cancer spread
- Global cancer drug spending to exceed $150 billion by 2020: IMS report
- AstraZeneca ovarian cancer drug slows disease markedly in study
- Newcomers to Asia banking scene fight for survival
- Classical drama seeks ways to survive
- Trump shakes up campaign, names combative news executive in senior role Reuters
Dean Baquet, The NYT’s Executive Editor, on Jill Abramson, Race, Surviving Cancer—and TMZ Envy have 284 words, post on www.thedailybeast.com at September 16, 2014. This is cached page on Auto Breaking News. If you want remove this page, please contact us.